Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or Urticaria
Phase of Trial: Phase IV
Latest Information Update: 21 Apr 2017
At a glance
- Drugs Bilastine (Primary)
- Indications Allergic rhinitis; Urticaria
- Focus Therapeutic Use
- Sponsors Menarini
- 22 Jan 2016 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 28 Oct 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 22 Oct 2015 New trial record